Where Are All the Women in Industry Advisory Boards?

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Brian M. Alexander

Employment: Foundation Medicine

Leadership: Foundation Medicine

Stock and Other Ownership Interests: Roche

Research Funding: Lilly (Inst), Puma Biotechnology (Inst), Celgene (Inst)

Open Payments Link: https://openpaymentsdata.cms.gov/physician/854258/summary

Janice M. Mehnert

Stock and Other Ownership Interests: Pfizer

Honoraria: EMD Serono, Pfizer

Consulting or Advisory Role: Merck Sharp & Dohme, Sanofi/Regeneron, Bristol Myers Squibb, Seattle Genetics, Eisai, Novartis

Research Funding: Amgen (Inst), AstraZeneca (Inst), Incyte (Inst), MacroGenics (Inst), Bristol Myers Squibb (Inst), Merck (Inst), Novartis (Inst), Regeneron (Inst)

Travel, Accommodations, Expenses: EMD Serono, Merck Sharp & Dohme, Array BioPharma, Bristol Myers Squibb

Rachna T. Shroff

Consulting or Advisory Role: Exelixis, Merck, QED Therapeutics, Incyte, AstraZeneca, Taiho Pharmaceutical, Boehringer Ingelheim, SERVIER, Genentech, Basilea

Research Funding: Pieris Pharmaceuticals, Taiho Pharmaceutical, Merck, Exelixis, QED Therapeutics, Rafael Pharmaceuticals, Bristol Myers Squibb, Bayer, Immunovaccine, Seattle Genetics, Novocure, NuCana, Loxo/Lilly, Faeth Therapeutics, NGM Biopharmaceuticals

Jennifer L. Yessaian

Employment: ITM Isotope Technologies Munich

Stock and Other Ownership Interests: Novartis

Other Relationship: Help with Hope

Pamela L. Kunz

Stock and Other Ownership Interests: Guardant Health

Consulting or Advisory Role: Ipsen, Lexicon, Sun Pharma, Acrotech Biopharma, Advanced Accelerator Applications/Novartis, Genentech/Roche, Amgen, Crinetics Pharmaceuticals, RayzeBio, Natera, HUTCHMED

Research Funding: Lexicon (Inst), Ipsen (Inst), Xencor (Inst), Brahms (Inst), Advanced Accelerator Applications/Novartis (Inst)

Open Payments Link: https://openpaymentsdata.cms.gov/physician/191388

Karyn A. Goodman

Consulting or Advisory Role: RenovoRx, Roche/Genentech, Novartis, Philips Healthcare

Other Relationship: National Cancer Institute

Susan E. Moran

Employment: RayzeBio, QED Therapeutics

Leadership: BioAtla

Stock and Other Ownership Interests: RayzeBio, BridgeBio Pharma, BioAtla, QED Therapeutics

Consulting or Advisory Role: Olema Pharmaceuticals

Patents, Royalties, Other Intellectual Property: PCT/US20/34881: Methods of Treating Cholangiocarcinoma; PCT/US20/35140: Methods for Treating Urinary System Cancers; Stabilized Compositions of Radionuclides and Uses Thereof

Jennifer M. Mills

Employment: Foundation Medicine, Genentech/Roche

Stock and Other Ownership Interests: Merck, Abbott Laboratories, AbbVie, Roche

Quita B. Highsmith

Employment: Genentech/Roche

Leadership: Genentech/Roche

Stock and Other Ownership Interests: Genentech/Roche

Travel, Accommodations, Expenses: Genentech/Roche

Julie M. Vose

Honoraria: Acerta Pharma/AstraZeneca, Roche/Genentech, MorphoSys, Conjupro Biotherapeutics, Oncternal Therapeutics, Johnson and Johnson, MEI Pharma, Lilly

Research Funding: Celgene (Inst), Incyte (Inst), Acerta Pharma (Inst), Kite, a Gilead company (Inst), Seattle Genetics (Inst), Novartis (Inst), Bristol Myers Squibb (Inst), AstraZeneca (Inst), Loxo, Epizyme

Lance Baldo

Employment: Freenome

Leadership: Freenome

Stock and Other Ownership Interests: Freenome, Adaptive Biotechnologies

No other potential conflicts of interest were reported.